Harvard Health Letter

By the way, doctor: Should I get the prostate cancer test I've heard about?

Q. I heard about a new test for prostate cancer that's better than the PSA test. Should I get this test?

A. You're probably talking about the EPCA-2 test. EPCA stands for early prostate cancer antigen. Johns Hopkins researchers have identified EPCA-2 as one of the proteins present in the nucleus of prostate cancer cells when they turn cancerous. Small amounts leak into the bloodstream, so EPCA-2 can be measured with a relatively simple blood test.

In April, the Hopkins group reported results showing that the EPCA-2 test was very accurate in telling the difference between cancer that was confined to the prostate and cancer that had spread outside the gland.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »